Company intelligence / Profile preview

betapharm Arzneimittel

Augsburg, Bavaria, Germanybetapharm.de ↗

Ownership: Private
Employees: ~1000
Development stage: Other

Overview

betapharm Arzneimittel is a leading German pharmaceutical company specializing in the development and commercialization of high-quality generic medicines. It operates as a major player in the German generics market and was acquired by Dr. Reddy’s Laboratories in 2006 for €480 million ($570 million). The company continues to provide affordable healthcare solutions with a focus on quality and accessibility.

Therapeutic areas: Other
Modalities: Small moleculeGeneric drugs
Industry: Biotech

Partnerships

Leverages parent company Dr. Reddy’s global manufacturing and product development infrastructure

Beyond the preview

Go deeper on betapharm Arzneimittel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on betapharm Arzneimittel.